↓ Skip to main content

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease

Overview of attention for article published in Alzheimer's Research & Therapy, November 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

policy
1 policy source
twitter
3 X users
patent
1 patent

Citations

dimensions_citation
86 Dimensions

Readers on

mendeley
126 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer’s disease
Published in
Alzheimer's Research & Therapy, November 2013
DOI 10.1186/alzrt224
Pubmed ID
Authors

Raj C Shah, Patrick J Kamphuis, Sue Leurgans, Sophie H Swinkels, Carl H Sadowsky, Anke Bongers, Stephen A Rappaport, Joseph F Quinn, Rico L Wieggers, Philip Scheltens, David A Bennett

Abstract

Souvenaid® containing Fortasyn® Connect is a medical food designed to support synapse synthesis in persons with Alzheimer's disease (AD). Fortasyn Connect includes precursors (uridine monophosphate; choline; phospholipids; eicosapentaenoic acid; docosahexaenoic acid) and cofactors (vitamins E, C, B12, and B6; folic acid; selenium) for the formation of neuronal membranes. Whether Souvenaid slows cognitive decline in treated persons with mild-to-moderate AD has not been addressed.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 126 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 126 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 17%
Student > Bachelor 20 16%
Student > Ph. D. Student 14 11%
Student > Master 12 10%
Other 10 8%
Other 19 15%
Unknown 30 24%
Readers by discipline Count As %
Medicine and Dentistry 30 24%
Agricultural and Biological Sciences 13 10%
Neuroscience 11 9%
Biochemistry, Genetics and Molecular Biology 7 6%
Nursing and Health Professions 5 4%
Other 23 18%
Unknown 37 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 October 2021.
All research outputs
#4,814,222
of 26,017,215 outputs
Outputs from Alzheimer's Research & Therapy
#1,068
of 1,494 outputs
Outputs of similar age
#52,096
of 326,120 outputs
Outputs of similar age from Alzheimer's Research & Therapy
#6
of 19 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 81st percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,494 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.5. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 326,120 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.